Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Nobel Laureate Dr. William C. Campbell: A man of character, passion and art
  • USA - English


News provided by

Edgewood Retirement Community

Oct 29, 2015, 10:55 ET

Share this article

Share toX

Share this article

Share toX

NORTH ANDOVER, MASSACHUSETTS (PRWEB) October 29, 2015 -- Nestled amongst almost 300 acres of conservation land and nature preserve on the shores of Lake Cochichewick, Edgewood Retirement Community is a picturesque, Shaker-style enclave more reminiscent of a quaint New England village than what one might normally think of as a retirement community. Residents — called members here — are an active lot who come from a wide variety of backgrounds, with lists of accomplishments and resumes that would impress, but are rarely flaunted.

Recently, however, the community was set abuzz by the news that one of its members is the recipient of the 2015 Nobel Prize in Physiology or Medicine. Dr. William C. Campbell, known to his friends as Bill, is a parasitologist who spent a storied career of more than 30 years at Merck Research Laboratories, where he made several discoveries that advanced the study of parasites and parasitic diseases. Chief among his accomplishments — and the subject of his Nobel Prize — was his role in developing the medication that treats onchocerciasis, or River Blindness. A debilitating and disfiguring disease caused by a parasitic worm found primarily in central and western Africa, onchocerciasis is the second most common cause of blindness due to infection.

A noble mission
Just as remarkable as his discovery is the character of the man himself. When Campbell realized that the compound he was investigating for use in animals might be the answer to River Blindness in humans, he wrote a memorandum to the then head of the Merck Research Laboratories. Even if his hypothesis were correct, the development of the drug was a long shot that would cost the company millions of dollars to develop for human use and conduct trials in the Third World. Moreover, even if a safe and effective drug could be produced, almost none of the people affected with river blindness would be able to afford it. Campbell’s memorandum started a process that not only led to the development of Mectizan® (ivermectin), but also to a donation program through which Merck has distributed the medication free of charge to the people who needed it, as long as they needed it. Through an international partnership with The Carter Center, three countries — Colombia, Ecuador, and Mexico — have received official verification of onchocerciasis elimination since 2013.

A life-long passion
Campbell’s interest in parasites began at an early age, when he was a child growing up in Donegal, Ireland. “I sometimes think I was born interested in parasites,” he says, adding that he remembers attending an agricultural show in Belfast and bringing home a pamphlet about a drug to treat parasites in sheep. “I was immediately fascinated by that,” he recalls.

While he retired from Merck in 1990, Campbell was inducted into the National Academy of Sciences in 2002 and remains active in his field. He continues to support and inspire students, serving as a Fellow in the Research Institute for Scientists Emeriti (RISE) — a program at Drew University in Madison, NJ, that pairs undergraduates with eminent scientists. He also remains an active and ardent supporter of The American Society of Parasitologists, often donating his paintings — which tend to set off bidding wars — to raise money to support graduate students in attending the Society’s meetings.

Yes, Nobel Laureate Campbell is also a prolific artist and poet. And his favorite subject matter is, as one would expect — parasites. He is an avid painter of colorful pictures that have been called “parasite surrealism,” and writes thought-provoking poems that explore the complex interrelationship of parasites, humans and society.

A rich life
Some may find it surprising that Campbell and his wife of more than fifty years choose to live in a retirement community. Yet Campbell says the lifestyle has exceeded his expectations. “My wife and I love the physical and mental activities offered at Edgewood. There are all kinds of projects and committees one can serve on. We enjoy the culture of continuous learning, the friendliness of the residents and staff, the country location that gives us access to the lake, the woods, walking trails, and more — we are very happy here.”

The affection is mutual. During a reception given in his honor at Edgewood Retirement Community on Wednesday, October 21, close to 100 of Dr. Campbell’s fellow residents, friends and staff members showed their support and appreciation for his life, work, and friendship. In her remarks, Edgewood President and CEO Marlene Rotering noted “I’ve heard it not once but many times: it couldn’t have happened to a nicer man! We are so grateful to Dr. Campbell for his many contributions — not only to our community as an active member and frequent lecturer in the Edgewood Lifelong Learning program, but also to the betterment of humanity and the world.”
__________________________________________________

CONTACT:
Kathleen Damico
Marketing Director
Edgewood Retirement Community, Inc.
Telephone: (978) 738-401
Email: damicokathleen(at)EdgewoodRC(dot)com

END
###

Kathleen Damico, Edgewood Retirement Community, http://www.edgewoodrc.com, +1 978 725 3300, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.